GlassScriptPhysician profile
Meredith W Cousin
NPI 1952305534
$6,227.51
in general payments reported to CMS, 2019-2025
54 companies · $900 in 2025
The $900 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $515 · 2021: $872 · 2022: $553 · 2023: $1,166 · 2024: $1,237 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,203 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,203.12 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,106.34 | 2021-2025 | Qulipta, Ubrelvy, Duopa |
| Jazz Pharmaceuticals INC. | $635.03 | 2019-2025 | Xywav |
| Mdd US Operations, LLC | $532.62 | 2019-2025 | Apokyn, Apokyn |
| Ucb, INC. | $471.54 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Supernus Pharmaceuticals, INC. | $358.18 | 2019-2022 | |
| Pfizer INC. | $237.70 | 2019-2025 | |
| Harmony Biosciences LLC | $230.45 | 2022-2025 | Wakix |
| Sunovion Pharmaceuticals INC. | $183.20 | 2019 | |
| Novartis Pharmaceuticals Corporation | $182.61 | 2019-2024 | |
| Neurocrine Biosciences, INC. | $164.43 | 2021-2025 | Ingrezza, Ongentys |
| Catalyst Pharmaceuticals, INC. | $162.19 | 2023-2024 | Fycompa, Firdapse |
| Biogen, INC. | $160.83 | 2020-2025 | Skyclarys, Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $155.94 | 2021 | |
| Emd Serono, INC. | $153.57 | 2019-2021 | |
| Medtronic, INC. | $118.16 | 2023 | Solitaire X |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Cousin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.